TY - CHAP M1 - Book, Section TI - Incontinence MTM Data Set A1 - Anderson, Katherine Vogel A1 - E. Honaker, Sarah A2 - Whalen, Karen A2 - Hardin, Heather C. PY - 2018 T2 - Medication Therapy Management: A Comprehensive Approach, 2e AB - KEY POINTSMedication therapy management (MTM) providers should screen for medications that may contribute to urinary incontinence.A combination of behavioral and drug therapies is the mainstay of treatment of urinary incontinence. Adherence to behavioral therapies should be assessed at each MTM encounter.Medications for urinary incontinence are often difficult to tolerate because of the anticholinergic effects; elderly patients may be particularly susceptible to these adverse effects.MTM providers should work with the patient and the prescriber to find the most acceptable regimen and help manage the adverse effects of medications for urinary incontinence. SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/03/28 UR - accesspharmacy.mhmedical.com/content.aspx?aid=1150201115 ER -